FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

32430311000001100: Voleze 13.3mg/24hours transdermal patches (Focus Pharmaceuticals Ltd) 30 patch (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Apr 2016. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
98663201000001112 Voleze 13.3mg/24hours transdermal patches (Focus Pharmaceuticals Ltd) 30 patch (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
111555501000001118 Voleze 13.3mg/24hours transdermal patches (Advanz Pharma) 30 patch en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Voleze 13.3mg/24hours transdermal patches (Focus Pharmaceuticals Ltd) 30 patch Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Voleze 13.3mg/24hours transdermal patches (Focus Pharmaceuticals Ltd) 30 patch Discontinued indicator Discontinued AMPP(qualifier value) true Inferred relationship Existential restriction modifier
Voleze 13.3mg/24hours transdermal patches (Focus Pharmaceuticals Ltd) 30 patch Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Voleze 13.3mg/24hours transdermal patches (Focus Pharmaceuticals Ltd) 30 patch Is a Rivastigmine 13.3mg/24hours transdermal patches 30 patch true Inferred relationship Existential restriction modifier
Voleze 13.3mg/24hours transdermal patches (Focus Pharmaceuticals Ltd) 30 patch Has AMP Voleze 13.3mg/24hours transdermal patches (Focus Pharmaceuticals Ltd) true Inferred relationship Existential restriction modifier
Voleze 13.3mg/24hours transdermal patches (Focus Pharmaceuticals Ltd) 30 patch Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Voleze 13.3mg/24hours transdermal patches (Focus Pharmaceuticals Ltd) 30 patch VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Voleze 13.3mg/24hours transdermal patches (Focus Pharmaceuticals Ltd) 30 patch VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Voleze 13.3mg/24hours transdermal patches (Focus Pharmaceuticals Ltd) 30 patch Has specific active ingredient Rivastigmine true Inferred relationship Existential restriction modifier
Voleze 13.3mg/24hours transdermal patches (Focus Pharmaceuticals Ltd) 30 patch Has dispensed dose form Prolonged-release transdermal patch true Inferred relationship Existential restriction modifier
Voleze 13.3mg/24hours transdermal patches (Focus Pharmaceuticals Ltd) 30 patch Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Voleze 13.3mg/24hours transdermal patches (Focus Pharmaceuticals Ltd) 30 patch Discontinued indicator Never discontinued false Inferred relationship Existential restriction modifier
Voleze 13.3mg/24hours transdermal patches (Focus Pharmaceuticals Ltd) 30 patch Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start